Chang Gung University
Taoyuan, 333, Taiwan
NCT Number: NCT02017938
Fatigue is one of the most common symptoms in individuals with Parkinson's Disease (PD). Past researches indicated that more than half of the individuals with PD demonstrated fatigue symptom. The severity of fatigue was also correlated to the quality of life in individuals with PD. Finding the contributions of the central and the peripheral factors to fatigue, building reliable fatigue indexes, and developing an effective training program for individuals with PD are very important.
The purpose of this project is to develop non-invasive method to monitor central and peripheral fatigue, to establish Virtual Reality(VR) anti-fatigue ergo cycling training paradigm, and to evaluate the long term training effect in individuals with PD.
Looking for future studies?
Notify Me20 year and older
All sexes
Interventional
Not applicable
Taoyuan, 333, Taiwan
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
To establish a Virtual Reality systems to reduce fatigue of cycling training for PD subjects.
Time frame: baseline, 1 week
Measure of changes in muscle twitch force by interpolation twitch technique.
Time frame: Baseline,1 week
Measure of changes in muscle voluntary activity level by interpolation twitch technique.
Time frame: Baseline,1 week
Measure of changes in Heart rate/Heart rate variability.
Time frame: Baseline,1 week
Measure of changes in Borg's rate of perceived exertion.
Chang Gung University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07736014
Basal Ganglia Diseases, Brain Diseases
Foggia, FG, Italy
View Trial DetailsNCT07629063
Atrophy, Basal Ganglia Diseases
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07659405
Basal Ganglia Diseases, Brain Diseases
Aarhus, Denmark
View Trial DetailsNCT07422064
Basal Ganglia Diseases, Brain Diseases
Gaziantep, Turkey (Türkiye)
View Trial Details